These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 37445688)

  • 1. Virtual Screening Strategy and In Vitro Tests to Identify New Inhibitors of the Immunoproteasome.
    Culletta G; Tutone M; Ettari R; Perricone U; Di Chio C; Almerico AM; Zappalà M
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of Novel Amides as Noncovalent Inhibitors of Immunoproteasomes.
    Ettari R; Cerchia C; Maiorana S; Guccione M; Novellino E; Bitto A; Grasso S; Lavecchia A; Zappalà M
    ChemMedChem; 2019 Apr; 14(8):842-852. PubMed ID: 30829448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of 2-thioxoimidazolidin-4-one derivatives as novel noncovalent proteasome and immunoproteasome inhibitors.
    Maccari R; Ettari R; Adornato I; Naß A; Wolber G; Bitto A; Mannino F; Aliquò F; Bruno G; Nicolò F; Previti S; Grasso S; Zappalà M; Ottanà R
    Bioorg Med Chem Lett; 2018 Feb; 28(3):278-283. PubMed ID: 29292224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fragment-Sized and Bidentate (Immuno)Proteasome Inhibitors Derived from Cysteine and Threonine Targeting Warheads.
    Kollár L; Gobec M; Proj M; Smrdel L; Knez D; Imre T; Gömöry Á; Petri L; Ábrányi-Balogh P; Csányi D; Ferenczy GG; Gobec S; Sosič I; Keserű GM
    Cells; 2021 Dec; 10(12):. PubMed ID: 34943940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based design of β1i or β5i specific inhibitors of human immunoproteasomes.
    de Bruin G; Huber EM; Xin BT; van Rooden EJ; Al-Ayed K; Kim KB; Kisselev AF; Driessen C; van der Stelt M; van der Marel GA; Groll M; Overkleeft HS
    J Med Chem; 2014 Jul; 57(14):6197-209. PubMed ID: 25006746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of isoquinolinone derivatives as immunoproteasome inhibitors.
    Ettari R; Iraci N; Di Chio C; Previti S; Danzè M; Zappalà M
    Bioorg Med Chem Lett; 2022 Jan; 55():128478. PubMed ID: 34838650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-γ-induced upregulation of immunoproteasome subunit assembly overcomes bortezomib resistance in human hematological cell lines.
    Niewerth D; Kaspers GJ; Assaraf YG; van Meerloo J; Kirk CJ; Anderl J; Blank JL; van de Ven PM; Zweegman S; Jansen G; Cloos J
    J Hematol Oncol; 2014 Jan; 7():7. PubMed ID: 24418325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Argyrin B, a non-competitive inhibitor of the human immunoproteasome exhibiting preference for β1i.
    Allardyce DJ; Bell CM; Loizidou EZ
    Chem Biol Drug Des; 2019 Aug; 94(2):1556-1567. PubMed ID: 31074944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of N, C-capped di- and tripeptides as selective immunoproteasome inhibitors.
    Nan G; Huang L; Li Y; Yang Y; Yang Y; Li K; Lai F; Chen X; Xiao Z
    Eur J Med Chem; 2022 Apr; 234():114252. PubMed ID: 35286927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of Immunoproteasome Inhibitors Using Large-Scale Covalent Virtual Screening.
    Scarpino A; Bajusz D; Proj M; Gobec M; Sosič I; Gobec S; Ferenczy GG; Keserű GM
    Molecules; 2019 Jul; 24(14):. PubMed ID: 31315311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoproteasome and Non-Covalent Inhibition: Exploration by Advanced Molecular Dynamics and Docking Methods.
    Culletta G; Zappalà M; Ettari R; Almerico AM; Tutone M
    Molecules; 2021 Jul; 26(13):. PubMed ID: 34279386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of α-amido boronic acids via cryo-electron microscopy analysis: Discovery of a novel highly selective immunoproteasome subunit LMP7 (β5i)/LMP2 (β1i) dual inhibitor.
    Arai Y; Shitama H; Yamagishi M; Ono S; Kashima A; Hiraizumi M; Tsuda N; Katayama K; Tanaka K; Koda Y; Kato S; Sakata K; Nureki O; Miyazaki H
    Bioorg Med Chem; 2024 Jul; 109():117790. PubMed ID: 38906067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonpeptidic Selective Inhibitors of the Chymotrypsin-Like (β5 i) Subunit of the Immunoproteasome.
    Sosič I; Gobec M; Brus B; Knez D; Živec M; Konc J; Lešnik S; Ogrizek M; Obreza A; Žigon D; Janežič D; Mlinarič-Raščan I; Gobec S
    Angew Chem Int Ed Engl; 2016 May; 55(19):5745-8. PubMed ID: 27037901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-covalent immunoproteasome inhibitors induce cell cycle arrest in multiple myeloma MM.1R cells.
    Ettari R; Pallio G; Pizzino G; Irrera N; Zappalà M; Maiorana S; Di Chio C; Altavilla D; Squadrito F; Bitto A
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1307-1313. PubMed ID: 31307247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The immunoproteasomes are key to regulate myokines and MHC class I expression in idiopathic inflammatory myopathies.
    Bhattarai S; Ghannam K; Krause S; Benveniste O; Marg A; de Bruin G; Xin BT; Overkleeft HS; Spuler S; Stenzel W; Feist E
    J Autoimmun; 2016 Dec; 75():118-129. PubMed ID: 27522114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-Based Design of Fluorogenic Substrates Selective for Human Proteasome Subunits.
    Maurits E; Degeling CG; Kisselev AF; Florea BI; Overkleeft HS
    Chembiochem; 2020 Nov; 21(22):3220-3224. PubMed ID: 32598532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of peptide epoxyketones as selective immunoproteasome inhibitors.
    Li X; Hong D; Zhang M; Xu L; Zhou Y; Li J; Liu T
    Eur J Med Chem; 2021 Oct; 221():113556. PubMed ID: 34087498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of selective fragment-sized immunoproteasome inhibitors.
    Kollár L; Gobec M; Szilágyi B; Proj M; Knez D; Ábrányi-Balogh P; Petri L; Imre T; Bajusz D; Ferenczy GG; Gobec S; Keserű GM; Sosič I
    Eur J Med Chem; 2021 Jul; 219():113455. PubMed ID: 33894528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-Activity Relationships of Noncovalent Immunoproteasome β5i-Selective Dipeptides.
    Zhan W; Singh PK; Ban Y; Qing X; Ah Kioon MD; Fan H; Zhao Q; Wang R; Sukenick G; Salmon J; Warren JD; Ma X; Barrat FJ; Nathan CF; Lin G
    J Med Chem; 2020 Nov; 63(21):13103-13123. PubMed ID: 33095579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoproteasome subunit β5i regulates diet-induced atherosclerosis through altering MERTK-mediated efferocytosis in Apoe knockout mice.
    Liao J; Xie Y; Lin Q; Yang X; An X; Xia Y; Du J; Wang F; Li HH
    J Pathol; 2020 Mar; 250(3):275-287. PubMed ID: 31758542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.